IP Library Granted Patent US 7,846,970
Granted Patent B2
US 7,846,970 · App. 11/663,422 · Granted Dec 7, 2010

Hydroxycitric acid derivatives and skin external preparations containing the same

Assignee: Showa Denko K.K.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,846,970
App. No.
11/663,422
Granted
Dec 7, 2010
Kind
B2
Abstract

Hydroxycitric acid derivatives and salts thereof are provided which are useful as active ingredients of skin external preparations and cosmetics. Also provided are processes for production of the hydroxycitric acid derivatives, and skin external preparations and cosmetics containing the hydroxycitric acid derivatives. Specific hydroxycitric acid derivatives or salts thereof are produced wherein at least one of the hydroxyl groups of hydroxycitric acid or least one of the hydroxyl groups and at least one carboxyl group of hydroxycitric acid are modified to linkage moieties breakable by biological enzyme reaction. The hydroxycitric acid derivatives or salts thereof are added in skin external preparations and cosmetics.

Claims (35)

1. A hydroxycitric acid derivative represented by the formula (I) below or salt thereof:

wherein R 1 and R 2 are each a hydrogen atom or a group removable by biological enzyme reaction (with the proviso that R 1 and R 2 cannot be hydrogen atoms at the same time), the removable group being selected from those represented by the formula (Ia) below; X 1 to X 3 are each a nitrogen atom or an oxygen atom; and R 3 , R 4 , R 5 , R 3′ , R 4′ and R 5′ are each a hydrogen atom or a chain hydrocarbon group of 1 to 30 carbon atoms that may have a branch or an unsaturated bond (with the proviso that when any of X 1 , X 2 and X 3 is an oxygen atom, corresponding R 3′ , R 4′ or R 5′ does not exist);

wherein R 6 is a hydrogen atom, a phenyl group, a naphthyl group, a furyl group, a thienyl group, a pyridyl group, or a chain hydrocarbon group of 7 to 23 carbon atoms that may have a branch, an unsaturated bond or a substituent group selected from the group consisting of a halogen atom, an amino group, a cyano group, an alkoxy group and a nitro group, and R 7 and R 8 are each a hydrogen atom, an aryl group, or a chain hydrocarbon group of 1 to 30 carbon atoms that may have a branch, an unsaturated bond or a substituent group selected from the group consisting of a halogen atom, an amino group, a cyano group, an alkoxy group and a nitro group.

2. The hydroxycitric acid derivative or salt thereof according to claim 1 , wherein in the formula (Ia), R 6 is a chain hydrocarbon group of 7 to 23 carbon atoms that may have a branch, an unsaturated bond or a substituent group selected from the group consisting of a halogen atom, an amino group, a cyano group, an alkoxy group and a nitro group, and R 7 and R 8 are each a hydrogen atom or a chain hydrocarbon group of 8 to 24 carbon atoms that may have a branch, an unsaturated bond or a substituent group selected from the group consisting of a halogen atom, an amino group, a cyano group, an alkoxy group and a nitro group.

3. The hydroxycitric acid derivative or salt thereof according to claim 1 , wherein in the formula (I), R 3 to R 5 are each a hydrogen atom or a chain hydrocarbon group of 1 to 30 carbon atoms that may have a branch or an unsaturated bond, and X 1 to X 3 are all oxygen atoms; and

wherein in the formula (Ia), R 6 is a chain hydrocarbon group of 7 to 23 carbon atoms that may have a branch, an unsaturated bond or a substituent group selected from the group consisting of a halogen atom, an amino group, a cyano group, an alkoxy group and a nitro group, and R 7 and R 8 are each a hydrogen atom or a chain hydrocarbon group of 8 to 24 carbon atoms that may have a branch, an unsaturated bond or a substituent group selected from the group consisting of a halogen atom, an amino group, a cyano group, an alkoxy group and a nitro group.

4. The hydroxycitric acid derivative or salt thereof according to claim 1 , wherein in the formula (I), R 2 is a hydrogen atom, R 3 to R 5 are all hydrogen atoms, and X 1 to X 3 are all oxygen atoms; and

wherein in the formula (Ia), R 6 is a chain hydrocarbon group of 13 to 21 carbon atoms that may have a branch, an unsaturated bond or a substituent group selected from the group consisting of a halogen atom, an amino group, a cyano group, an alkoxy group and a nitro group.

5. The hydroxycitric acid derivative or salt thereof according to claim 1 , wherein in the formula (I), R 2 is a hydrogen atom, R 3 to R 5 are each a hydrogen atom or a chain hydrocarbon group of 1 to 30 carbon atoms that may have a branch or an unsaturated bond (with the proviso that R 3 to R 5 cannot be hydrogen atoms at the same time), and X 1 to X 3 are all oxygen atoms; and

wherein in the formula (Ia), R 6 is a chain hydrocarbon group of 13 to 21 carbon atoms that may have a branch, an unsaturated bond or a substituent group selected from the group consisting of a halogen atom, an amino group, a cyano group, an alkoxy group and a nitro group.

6. A process for producing the hydroxycitric acid derivative or salt thereof as described in claim 1 , which process comprises reacting hydroxycitric acid and/or an alkali metal salt thereof and/or an alkaline earth metal salt thereof, with a carboxylic acid derivative, a phosphoric acid derivative or a sulfonic acid derivative that is capable of in vivo cleavage, in a solvent.

7. A process for producing the hydroxycitric acid derivative or salt thereof as described in claim 4 , which process comprises:

a first step comprising reacting hydroxycitric acid and/or an alkali metal salt thereof and/or an alkaline earth metal salt thereof, with an alcohol in a solvent to prepare a hydroxycitric acid (tri)ester;

a second step comprising reacting the compound obtained in the first step with an aliphatic carboxylic acid derivative capable of in vivo cleavage to esterify a hydroxyl group of the compound obtained in the first step; and

a third step comprising cleaving ester linkage moieties of the compound obtained in the second step so as to cleave part or all of the ester linkage moieties formed in the first step.

8. A skin external preparation comprising the hydroxycitric acid derivative and/or salt thereof as described in claim 1 .

9. The skin external preparation according to claim 8 , wherein the preparation contains the hydroxycitric acid derivative and/or salt thereof in an amount of 0.01 to 20% by mass.

10. The skin external preparation according to claim 8 , wherein the preparation further contains a substance capable of increasing hormone-sensitive lipase activity.

11. The skin external preparation according to claim 8 , wherein the preparation further contains a substance capable of facilitating breakdown of fatty acids.

12. A cosmetic comprising the skin external preparation as described in claim 8 .

13. A process for producing the hydroxycitric acid derivative or salt thereof as described in claim 2 , which process comprises reacting hydroxycitric acid and/or an alkali metal salt thereof and/or an alkaline earth metal salt thereof, with a carboxylic acid derivative, a phosphoric acid derivative or a sulfonic acid derivative that is capable of in vivo cleavage, in a solvent.

14. A process for producing the hydroxycitric acid derivative or salt thereof as described in claim 3 , which process comprises reacting hydroxycitric acid and/or an alkali metal salt thereof and/or an alkaline earth metal salt thereof, with a carboxylic acid derivative, a phosphoric acid derivative or a sulfonic acid derivative that is capable of in vivo cleavage, in a solvent.

15. A process for producing the hydroxycitric acid derivative or salt thereof as described in claim 4 , which process comprises reacting hydroxycitric acid and/or an alkali metal salt thereof and/or an alkaline earth metal salt thereof, with a carboxylic acid derivative, a phosphoric acid derivative or a sulfonic acid derivative that is capable of in vivo cleavage, in a solvent.

16. A process for producing the hydroxycitric acid derivative or salt thereof as described in claim 5 , which process comprises reacting hydroxycitric acid and/or an alkali metal salt thereof and/or an alkaline earth metal salt thereof, with a carboxylic acid derivative, a phosphoric acid derivative or a sulfonic acid derivative that is capable of in vivo cleavage, in a solvent.

17. A process for producing the hydroxycitric acid derivative or salt thereof as described in claim 5 , which process comprises:

a first step comprising reacting hydroxycitric acid and/or an alkali metal salt thereof and/or an alkaline earth metal salt thereof, with an alcohol in a solvent to prepare a hydroxycitric acid (tri)ester;

a second step comprising reacting the compound obtained in the first step with an aliphatic carboxylic acid derivative capable of in vivo cleavage to esterify a hydroxyl group of the compound obtained in the first step; and

a third step comprising cleaving ester linkage moieties of the compound obtained in the second step so as to cleave part or all of the ester linkage moieties formed in the first step.

18. The skin external preparation according to claim 9 , wherein the preparation further contains a substance capable of increasing hormone-sensitive lipase activity.

19. The skin external preparation according to claim 9 , wherein the preparation further contains a substance capable of facilitating breakdown of fatty acids.

20. A cosmetic comprising the skin external preparation as described in claim 9 .

21. A cosmetic comprising the skin external preparation as described in claim 10 .

22. A cosmetic comprising the skin external preparation as described in claim 11 .

23. A cosmetic comprising the skin external preparation as described in claim 18 .

24. A cosmetic comprising the skin external preparation as described in claim 19 .

Assignments (3)
CHANGE OF ADDRESS Recorded Feb 14, 2024
From: RESONAC CORPORATION
To: RESONAC CORPORATION
Reel/Frame 066599/0037 →
CHANGE OF NAME Recorded Jun 23, 2023
From: SHOWA DENKO K.K.
To: RESONAC CORPORATION
Reel/Frame 064082/0513 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 21, 2007
From: KAMACHI, HARUMI; KATOH, TSUYOSHI; AOKI, HIROBUMI
To: SHOWA DENKO K.K.
Reel/Frame 019091/0212 →
Priority Claims (3)
JP 2004-276712 · Sep 24, 2004 · national
JP 2005-119826 · Apr 18, 2005 · national
JP 2005-185253 · Jun 24, 2005 · national
Continuity (3)
Provisional Application 6061432700 · Sep 30, 2004
Provisional Application 6067469200 · Apr 26, 2005
Related Publication 20070293577A1 · Dec 20, 2007